Table 1. Clinical characteristics of... | American Society of Hematology

Table 1.

Clinical characteristics of chronic hepatitis B patients treated with prophylactic lamivudine

Patient no.	Sex	Age, y	Basic disease	Immunosuppressive treatment	Outcome
1	F	49	Lymphoma	CHOP^*	Alive
2	F	65	Lymphoma	CHOP^*	Alive
3	M	44	Enophtalmitis	Steroids^†	Alive
4	M	57	Lymphoma	Cyclophosphamide, vincristine, prednisone^‡	Died
5	M	57	Cryoglobulinemia	Steroids^†	Alive
6	M	62	Colon carcinoma	5-FU^1-153	Alive
7	M	38	Lymphoma	CHOP^*	Died
8	M	55	Lymphoma	CHOP^*	Alive
9	M	56	Colon carcinoma	5-FU^1-153	Alive
10	M	65	Lymphoma	Chlorambucil^1-155	Alive
11	M	52	Vasculitis	Steroids,^†cyclophosphamide^1-154	Alive
12	M	42	Lymphoma	CHOP^*	Died
13	F	47	Ulcerative colitis	Steroids^†	Alive

Patient no.	Sex	Age, y	Basic disease	Immunosuppressive treatment	Outcome
1	F	49	Lymphoma	CHOP^*	Alive
2	F	65	Lymphoma	CHOP^*	Alive
3	M	44	Enophtalmitis	Steroids^†	Alive
4	M	57	Lymphoma	Cyclophosphamide, vincristine, prednisone^‡	Died
5	M	57	Cryoglobulinemia	Steroids^†	Alive
6	M	62	Colon carcinoma	5-FU^1-153	Alive
7	M	38	Lymphoma	CHOP^*	Died
8	M	55	Lymphoma	CHOP^*	Alive
9	M	56	Colon carcinoma	5-FU^1-153	Alive
10	M	65	Lymphoma	Chlorambucil^1-155	Alive
11	M	52	Vasculitis	Steroids,^†cyclophosphamide^1-154	Alive
12	M	42	Lymphoma	CHOP^*	Died
13	F	47	Ulcerative colitis	Steroids^†	Alive

The CHOP regimen was as follows: cyclophosphamide (750 mg/m²); vincristine (Oncovin) (1.4 mg/m²); doxorubicin (Adriamycin) (50 mg/m²) on day 1; and prednisone (100 mg) on days 1-5.

†

1 mg/kg prednisone by mouth (PO) and then tapering down.

‡

Modified CHOP (the doses of the other medications remain the same as in the regular CHOP).

F1-153

900 mg/m² 5-fluorouracil intravenously every 2 weeks.

F1-155

8 mg/day PO for 4 days every month.

F1-154

1 mg/kg every day PO.

[ViewLarge]